Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
AOD-9604 Jump to: Structure | Mechanism | Studies | Pharmacokinetics | Protocols | Limitations | Lead Researcher | References AOD-9604 Peptide Molecular Structure & Chemical Properties AOD-9604 represents a pioneering approach to peptide-based metabolic research, originally developed in the 1990s at Monash University in Australia as a potential anti-obesity therapeutic
In some cases, independent testing has revealed contaminants, degraded compounds, or dosages that are significantly higher or lower than advertised
Recent studies have shown that GLP-1(936) is particularly effective at low glucose concentrations, with its inhibitory effect being similar to that of GLP-1(7-36)
Injections offer the highest bioavailability for systemic effects
In a 26-week study, orforglipron demonstrated a significant dose-dependent effect on weight loss, with weight reduction ranging from 8.6% to 12.6% across various dosages, compared to only 2.0% in the placebo group
Stable Gastric Pentadecapeptide BPC 157, Robert's Cytoprotection, Adaptive Cytoprotection, and Therapeutic Effects
US$ 25.94
US$ 28.26
US$ 29.52
US$ 26.49
US$ 28.06
US$ 25.93